Evolving Strategies for Renal Cell Carcinoma

Dr. Ashwin Singh Parihar sits down with Dr. Iben Lyskjær and Dr. Tommy Kjærgaard Nielsen to unpack new nationwide registry data comparing ablation and surgical approaches for small renal masses. Together, they explore how minimally invasive treatments stack up in real-world practice and what the findings mean for patient selection, outcomes, and future care decisions. Ablation and Surgery Show Comparable Long-term Outcomes for T1a Renal Cell Carcinoma: A Danish Nationwide Registry Study. Ahrenfeldt et al. Radiology 2026; 318(3):e251485.